Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Exploring Secretin's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
15 September 2023
This article summarized the latest R&D progress of Secretin, the Mechanism of Action for Secretin, and the drug target R&D trends for Secretin.
Valuable Targets
5 min read
CDK4 Inhibitor - A Highly Noticed Breast Cancer Treatment Drug
15 September 2023
CDK4, or cyclin-dependent kinase 4, is a crucial protein involved in cell cycle regulation in the human body.
Drug Insights
4 min read
Decoding Riluzole: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
15 September 2023
This article summarized the latest R&D progress of Riluzole, the Mechanism of Action for Riluzole, and the drug target R&D trends for Riluzole.
Latest Hotspot
3 min read
Promising results were noted in Phase 1b of the TROPION-Lung04 trial, combining Datopotamab Deruxtecan and Durvalumab for Non-Small Cell Lung Cancer
15 September 2023
Promising clinical responses were observed in TROPION-Lung04's Phase 1b Trial with a combination of Datopotamab Deruxtecan and Durvalumab with Non-Small Cell Lung Cancer.
Drug Insights
4 min read
Deep Scientific Insights on Ranolazine's R&D Progress,Drug Target
15 September 2023
This article summarized the latest R&D progress of Ranolazine, the Mechanism of Action for Ranolazine, and the drug target R&D trends for Ranolazine.
Valuable Targets
7 min read
CDK2 Inhibitor——Important Regulator of Cell Cycle Control
15 September 2023
CDK2, or cyclin-dependent kinase 2, is a crucial protein involved in cell cycle regulation in the human body.
Drug Insights
4 min read
An In-depth Analysis of Ramelteon's R&D Progress
15 September 2023
This article summarized the latest R&D progress of Ramelteon, the Mechanism of Action for Ramelteon, and the drug target R&D trends for Ramelteon.
Latest Hotspot
4 min read
The HERTHENA-Lung01 Phase 2 Trial demonstrated significant, lasting effects of Patritumab Deruxtecan in non-small cell lung cancer patients
15 September 2023
The HERTHENA-Lung01 Phase 2 Trial showed that Patritumab Deruxtecan brought about meaningful and durable effects in Patients with non-small cell lung cancer.
Drug Insights
4 min read
Perphenazine: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
15 September 2023
This article summarized the latest R&D progress of Perphenazine, the Mechanism of Action for Perphenazine, and the drug target R&D trends for Perphenazine.
Valuable Targets
6 min read
CD38 inhibitors——New Hope for Multiple Myeloma Patients with Medications
15 September 2023
CD38 is a multifunctional enzyme found on the surface of various cells in the human body, including immune cells and certain tissues.
Drug Insights
4 min read
Decoding Oxybutynin Chloride: A Comprehensive Study of its R&D Trends
14 September 2023
This article summarized the latest R&D progress of Oxybutynin Chloride, the Mechanism of Action for Oxybutynin Chloride, and the drug target R&D trends for Oxybutynin Chloride.
Latest Hotspot
4 min read
Samsung Bioepis collaborates with Sandoz to market Ustekinumab Biosimilar Candidate
14 September 2023
Samsung Bioepis Co., Ltd. disclosed it has struck a commercialization pact with Sandoz regarding SB17, a potential biosimilar to Stelarai(ustekinumab).